Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MBNL1 alternative splicing isoforms play opposing roles in cancer.
Tabaglio T, Low DH, Teo WKL, Goy PA, Cywoniuk P, Wollmann H, Ho J, Tan D, Aw J, Pavesi A, Sobczak K, Wee DKB, Guccione E. Tabaglio T, et al. Among authors: aw j. Life Sci Alliance. 2018 Sep 7;1(5):e201800157. doi: 10.26508/lsa.201800157. eCollection 2018 Oct. Life Sci Alliance. 2018. PMID: 30456384 Free PMC article.
G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma.
Lam MSY, Reales-Calderon JA, Ow JR, Aw JJY, Tan D, Vijayakumar R, Ceccarello E, Tabaglio T, Lim YT, Chien WL, Lai F, Tanoto AT, Chen Q, Sobota RM, Adriani G, Bertoletti A, Guccione E, Pavesi A. Lam MSY, et al. Among authors: aw jjy. Nat Commun. 2023 Feb 2;14(1):563. doi: 10.1038/s41467-023-36160-5. Nat Commun. 2023. PMID: 36732506 Free PMC article.
Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma Using an Advanced Human In Vitro Model of the Blood-Brain Barrier and Glioblastoma.
Lam MS, Aw JJ, Tan D, Vijayakumar R, Lim HYG, Yada S, Pang QY, Barker N, Tang C, Ang BT, Sobota RM, Pavesi A. Lam MS, et al. Among authors: aw jj. Small. 2023 Dec;19(52):e2302280. doi: 10.1002/smll.202302280. Epub 2023 Aug 30. Small. 2023. PMID: 37649234
Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in Australia.
Deakin CT, De Stavola BL, Littlejohn G, Griffiths H, Ciciriello S, Youssef P, Mathers D, Bird P, Smith T, O'Sullivan C, Freeman T, Segelov D, Hoffman D, Seaman SR; OPAL Rheumatology Network. Deakin CT, et al. JAMA Netw Open. 2023 Jun 1;6(6):e2320851. doi: 10.1001/jamanetworkopen.2023.20851. JAMA Netw Open. 2023. PMID: 37382956 Free PMC article. Clinical Trial.
80 results